Search results
My 3 Top Stocks to Buy in June
247wallst.com· 2 days ago24/7 Insights Sell in May and go away? Maybe not this year, but be careful. Altria Group Inc. (NYSE MO) still owns 8% of Anheuser-Busch InBev S.A. (NYSE:...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
KAAL Austin· 1 day agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall — targeting a version of the ever-evolving coronavirus called JN ...
Pfizer Study Shows Lorbrena Reduces Chances of Lung Cancer Getting Worse
Morningstar· 7 days agoPfizer said a majority of patients in a study of its lung cancer treatment Lorbrena remained alive after five years without the disease worsening. The drugmaker disclosed ...
EU regulator recommends use of Pfizer's gene therapy for rare bleeding disorder
Reuters· 7 days agoThe European Medicines Agency has recommended the use of Pfizer's gene therapy for a rare bleeding...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 2 days agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 15 hours agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with...
Will there be a new Covid vaccine in the fall?
NBC News via Yahoo News· 1 day agohe added. The FDA is expected to make a final decision soon on which strain it will advise drugmakers to target. That will kickstart production of the...
Strong trial results for Pfizer lung cancer drug | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 7 days agoA Pfizer medicine has been shown to greatly reduce cancer progression and improve survival outcomes...
Why Is Novavax (NVAX) Stock Up 20% Today?
InvestorPlace· 1 day agoNovavax (NASDAQ:NVAX) is on a recovery trek after collapsing in late 2021. Regarding timeline, the latter two firms said that they would be able to...
GSK shares fall 9% in wake of Zantac court ruling
Pharmaceutical Technology via Yahoo Finance· 3 days agoPfizer, Boehringer Ingelheim, Sanofi, and Patheon are also implicated in the cases. In 2020, the US Food and Drug Administration (FDA) ordered the...
